Clinical trial of PROTECT-C hand sanitizer in SARS-CoV-2 infected subjects.
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/07/034624
- Lead Sponsor
- MIYAKAWA KOGYO INDIA PVT LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Tested SARS- CoV-2 positive within last 8 days of study enrolment.
Patients willing to sign written informed consent and are ready to comply to study procedure.
SARS-CoV-2 positive asymptomatic or symptomatic patients who are under institutional quarantine/ home isolated/ hospitalized.
Patients on ventilator support. Pregnant or lactating woman. Subjects with history of sun burn on hands. Subjects with history of skin disorders or on medication for the same: Eczema, Urticaria, Psoriasis, Herpes, skin cancer, Lupus, Vitiligo, Fungal infection, Candidiasis. Subjects on treatment of any degree burns. Any kind of psychiatric disorder or a condition in the opinion of the investigator may hinder communication with the research team. Inability of the subject to cooperate or communicate with the research team and provide follow up.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinically significant Quantitative Reduction of <br/ ><br>80% Virus load from baseline to EOT.Timepoint: 90 sec
- Secondary Outcome Measures
Name Time Method Tolerability and safety of interventionTimepoint: 90 sec